EP2568988
Lyfjablöndur sem innihalda 1-(beta-D-glúkópýranósýl)-2-þíenýlmetýlbensen afleiður sem hemlar af SGLT
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
11.5.2011EP published:
13.7.2016EP application number:
11721616.8
EP translation filed:
4.10.2016Grant published:
15.10.2016EPO information:
European Patent Register
Max expiry date:
10.5.2031Expiry date:
10.5.2022
Title:
PHARMACEUTICAL FORMULATIONS COMPRISING 1-(BETA-D-GLUCOPYRANOSYL)-2-THIENYLMETHYLBENZENE DERIVATIVES AS INHIBITORS OF SGLT
Timeline
Today
11.5.2011EP application
13.7.2016EP Publication
4.10.2016Translation submitted
15.10.2016Registration published
10.5.2022Expires
Owner
Name:
Janssen Pharmaceutica, N.V.Address:
Turnhoutseweg 30, 2340, Beerse, BE
Inventor
Name:
WANG, WenhuaAddress:
New HopePA, US
Name:
OUTWIN, ToddAddress:
ChalfontPA, US
Name:
JOSEPH, Thomas C.Address:
OakfordPA, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
333495 PDate:
11.5.2010Country:
US
Classification
Categories:
A61K 31/7042, A61K 31/7004, A61K 31/381, A61K 9/28, A61K 9/20, A61K 47/38, A61K 47/26, A61P 3/10
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 10.4.2017
Expires: 10.5.2018
Payer: Árnason Faktor
Number: 8
Paid: 9.4.2018
Expires: 10.5.2019
Payer: Árnason Faktor
Number: 9
Paid: 5.4.2019
Expires: 10.5.2020
Payer: Árnason Faktor
Number: 10
Paid: 7.4.2020
Expires: 10.5.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.4.2021
Expires: 10.5.2022
Payer: Árnason Faktor ehf.